David Levy-Booth
Publishes 1 feed
Dyno Therapeutics
Building high-performance genetic technologies that enable genetic agency
10 posts · contributor
Lately
Genetic medicine is about to be transformed by the agent economy
Claude Mythos Preview matches the best humans in solving Dyno’s sequence design challenge
Dyno Psi-Phi: Shaping new futures for protein design
Cultivating an ecosystem of trust through principled decision-making
Can AI agents solve the “last mile” problem in generative therapeutic design?
A Computational LEAP over an In vivo Experiment
Dyno is scaling gene therapy research with cloud-native tools like Argo Workflows and Hera
Introduction to AAV as a Gene Therapy Vector, Part 2
Introduction to AAV as a Gene Therapy Vector, Part 1
Delivering an experience our AAViators expect through Agile work practices
Everything on this page was read from markup David Levy-Booth published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON
